A Patient with Intractable Posthypoxic Myoclonus (Lance-Adams Syndrome) Treated with Sodium Oxybate
Authors:
Open Access
- 1 March 2009
- journal article
- research article
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 37 (2) , 314-318
Abstract
Posthypoxic myoclonus is a rare and devastating complication of near-fatal cardiopulmonary arrest. Despite treatment with available anti-myoclonic agents, some patients may recover cognitively but remain completely disabled by severe myoclonus. We report a 16-year-old patient with severe treatment-refractory posthypoxic myoclonus, which improved markedly with administration of the drug sodium oxybate.Keywords
This publication has 9 references indexed in Scilit:
- Coma After Global Ischemic Brain Injury: Pathophysiology and Emerging TherapiesCritical Care Clinics, 2008
- Movement Disorders after Resuscitation from Cardiac ArrestNeurologic Clinics, 2006
- ??-Hydroxybutyrate/Sodium OxybateCNS Drugs, 2006
- Marked amelioration of alcohol‐responsive posthypoxic myoclonus by γ‐hydroxybutyric acid (Xyrem)Movement Disorders, 2005
- Myoclonus: current concepts and recent advancesThe Lancet Neurology, 2004
- The clinical spectrum of posthypoxic myoclonusMovement Disorders, 2000
- Involvement of GABAA receptors in myoclonusMovement Disorders, 2000
- γ-Hydroxybutyric acid for alcohol-sensitive myoclonus with dystoniaNeurology, 2000
- THE SYNDROME OF INTENTION OR ACTION MYOCLONUS AS A SEQUEL TO HYPOXIC ENCEPHALOPATHYBrain, 1963